Therefore, the outcomes of our analysis should be interpreted cautiously and replication using brain transcriptomic information covering the whole AD spectrum, ideally with direct correspondence with in vivo or ex vivo imaging, is warranted to conclusively make inferences on the specific biological features underlying the vulnerability of early tau pathways from the LC to the cortex. Here, MAPT is linked to Alzheimer disease.